metahealth_logo.png

We deliver digital therapeutics for gut health

A digital therapeutic is a clinically proven software-based product that engages patients, allows clinicians to monitor, track-adherence and delivers consistent health outcomes. Our initial focus is Irritable Bowel Syndrome, a chronic and painful problem that affects 30M Americans, or 10% of the US population. Symptoms that include abdominal pain, bloating, with diarrhea or constipation (or mix of both). IBS (Irritable Bowel Syndrome) is an ideal candidate for treatment by a digital therapeutic because a primary underlying cause is neurological; a dysregulation of communication between the brain and the gut. This can result in visceral hypersensitivity, abnormal feelings of pain or discomfort from normal digestive processes.

Regulora for IBS

Regulora™ is based on an exclusively licensed brain-gut therapy protocol that is clinically proven to treat IBS effectively in multiple studies when delivered in-person. metaMe Health holds worldwide exclusive license for administration of the treatment protocol by electronic means. We also offer a version of Regulora™ specially designed to treat IBS in those that also suffer from Inflammatory Bowel Disease (IBD). 

A digital therapeutic for treatment of GERD (Functional Heartburn) is also in development.